Abstract:(a) In the skin fibroblasts are a key source of SASP production, with melanocytes having significantly less production. In healthy individuals, senescent fibroblasts play a major role in attracting T cells from the circulation by secreting SASP products. Recrutied T cells perform immunosurveillance, eliminating damaged and/malignant cells. (b) In the skin of patients with a CDKN2A mutation, multiple senescence‐related defects are present. Both melanocytes and fibroblasts exhibit reduced senescence but are highly susceptible to DNA damage. Senescent fibroblasts secrete reduced levels of SASP products resulting in reduced recruitment of T cells into the skin. This results in reduced immunosurveillance of damaged cells, especially melanocytes that increases the susceptibility of the patients to melanoma. The integrated behaviour of multiple senescent cell types within a single human tissue leading to the development of malignancy is unclear. Patients with Familial Melanoma Syndrome (FMS) have heterozygous germline defects in the CDKN2A gene coding for the cyclin inhibitor p16INK4a. Melanocytes within skin biopsies from FMS patients express significantly less p16INK4a but express higher levels of the DNA‐damage protein γH2AX a than fibroblastic cells. However, patient fibroblasts also exhibit defects since senescent cells do not increase in the skin during ageing and fibroblasts isolated from the skin of patients have increased replicative capacity compared to control fibroblasts in vitro, culminating in abnormal nuclear morphology. Patient derived fibroblasts also secreted less SASP than control cells. Predisposition of FMS patients to melanoma may therefore result from integrated dysregulation of senescence in multiple cell types in vivo. The inherently greater levels of DNA damage and the overdependence of melanocytes on p16 for cell cycle inhibition after DNA damage makes them exquisitely susceptible to malignant transformation. This may be accentuated by senescence‐related defects in fibroblasts, in particular reduced SASP secretion that hinders recruitment of T cells in the steady state and thus reduces cutaneous immunosurveillance in vivo.

Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction

Mapping epidermal and dermal cellular senescence in human skin aging

Senescent melanocytes driven by glycolytic changes are characterized by melanosome transport dysfunction

Senescent fibroblasts can drive melanoma initiation and progression

Cellular Senescence in Human Skin Aging: Leveraging Senotherapeutics

The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies

Senescent cell transplantation into the skin induces age-related peripheral dysfunction and cognitive decline

Cell Senescence-Independent Changes of Human Skin Fibroblasts with Age

Multiple outcomes of the germline p16INK4a mutation affecting senescence and immunity in human skin

Pleiotropic age-dependent effects of mitochondrial dysfunction on epidermal stem cells

Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition

Skin senescence—from basic research to clinical practice

Senescence in the ageing skin: a new focus on mTORC1 and the lysosome

Cellular senescence in skin‐related research: Targeted signaling pathways and naturally occurring therapeutic agents

Cell Autonomous and Non-Autonomous Effects of Senescent Cells in the Skin

Depletion of growth differentiation factor 15 (GDF15) leads to mitochondrial dysfunction and premature senescence in human dermal fibroblasts

Cutaneous Redox Senescence

Early Onset of Senescence and Imbalanced Epidermal Homeostasis Across the Decades in Photoexposed Human Skin: Fingerprints of Inflammaging

Looking for the philosopher's stone: Emerging approaches to target the hallmarks of aging in the skin

Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo

Targeting SIRT4/TET2 Signaling Alleviates Human Keratinocyte Senescence by Reducing 5-Hmc Loss